Literature DB >> 26023181

Normalization panels for the reliable quantification of circulating microRNAs by RT-qPCR.

Maayke G M Kok1, Amalia Halliani1, Perry D Moerland1, Joost C M Meijers1, Esther E Creemers1, Sara-Joan Pinto-Sietsma2.   

Abstract

Circulating microRNAs (miRNAs) have been reported as biomarkers for disease diagnosis. RT-qPCR is most commonly used to detect miRNAs; however, no consensus on the most appropriate method for data normalization exists. Via a standardized selection method, we aimed to determine separate miRNA normalization panels for RT-qPCR measurements on whole blood, platelets, and serum. Candidate miRNAs were selected from studies describing circulating miRNA microarray data in the Gene Expression Omnibus or ArrayExpress. miRNA expression data of healthy controls were retrieved from each study. For each sample type, we selected those miRNAs that were least variable and sufficiently highly expressed in multiple microarray experiments, performed on at least 2 different platforms. Stability of the candidate miRNAs was assessed using NormFinder and geNorm algorithms in a RT-qPCR cohort of 10 patients with coronary artery disease and 10 healthy controls. We selected miRNA normalization panels for RT-qPCR measurements on whole blood, platelets, and serum. As a validation, we assessed the precision of all 3 panels in 3 independent RT-qPCR cohorts and compared this with normalization for miR-16 or RNU6B. The proposed normalization panels for whole blood, platelets, and serum show better precision than normalization for miR-16 or RNU6B. © FASEB.

Entities:  

Keywords:  coronary artery disease; platelets; serum; whole blood

Mesh:

Substances:

Year:  2015        PMID: 26023181     DOI: 10.1096/fj.15-271312

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  38 in total

1.  Circulating microRNA biomarkers for cardiovascular risk prediction: are we approaching clinical application?

Authors:  Maurice W J de Ronde; Yigal M Pinto; Sara-Joan Pinto-Sietsma
Journal:  Ann Transl Med       Date:  2016-12

2.  Dysregulated circulating miRNAs in preeclampsia.

Authors:  Carine Munaut; Linda Tebache; Silvia Blacher; Agnès Noël; Michelle Nisolle; Frédéric Chantraine
Journal:  Biomed Rep       Date:  2016-10-14

Review 3.  Improving accuracy of RNA-based diagnosis and prognosis of oral cancer by using noninvasive methods.

Authors:  Guy R Adami; Jessica L Tang; Michael R Markiewicz
Journal:  Oral Oncol       Date:  2017-04-17       Impact factor: 5.337

Review 4.  Factors influencing circulating microRNAs as biomarkers for liver diseases.

Authors:  Shalini R Dubey; Tester F Ashavaid; Philip Abraham; Minal Umesh Paradkar
Journal:  Mol Biol Rep       Date:  2022-02-20       Impact factor: 2.742

Review 5.  Circulating microRNA-92a-3p in colorectal cancer: a review.

Authors:  Nami O Yamada; Takao Senda
Journal:  Med Mol Morphol       Date:  2021-02-23       Impact factor: 2.309

6.  Prospective Study on Plasma MicroRNA-4286 and Incident Acute Coronary Syndrome.

Authors:  Miaoyan Shen; Xuedan Xu; Xuezhen Liu; Qiuhong Wang; Wending Li; Xiaomin You; Rong Peng; Yu Yuan; Pinpin Long; Rundong Niu; Handong Yang; Xiang Cheng; An Pan; Robert M Tanguay; Xiaomin Zhang; Meian He; Chaolong Wang; Liming Liang; Tangchun Wu
Journal:  J Am Heart Assoc       Date:  2021-03-10       Impact factor: 5.501

7.  Evaluation of the performance of serum miRNAs as normalizers in microRNA studies focused on cardiovascular disease.

Authors:  Xiaoyan Wang; Xiaoyi Zhang; Jie Yuan; Jian Wu; Xin Deng; Juan Peng; Shijun Wang; Chunjie Yang; Junbo Ge; Yunzeng Zou
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

8.  CD99 regulates neural differentiation of Ewing sarcoma cells through miR-34a-Notch-mediated control of NF-κB signaling.

Authors:  S Ventura; D N T Aryee; F Felicetti; A De Feo; C Mancarella; M C Manara; P Picci; M P Colombo; H Kovar; A Carè; K Scotlandi
Journal:  Oncogene       Date:  2015-11-30       Impact factor: 9.867

9.  Methods to Investigate miRNA Function: Focus on Platelet Reactivity.

Authors:  Alix Garcia; Sylvie Dunoyer-Geindre; Richard J Fish; Marguerite Neerman-Arbez; Jean-Luc Reny; Pierre Fontana
Journal:  Thromb Haemost       Date:  2020-10-29       Impact factor: 5.249

Review 10.  Diagnostic, prognostic and predictive value of cell-free miRNAs in prostate cancer: a systematic review.

Authors:  Edgars Endzeliņš; Vita Melne; Zane Kalniņa; Vilnis Lietuvietis; Una Riekstiņa; Alicia Llorente; Aija Linē
Journal:  Mol Cancer       Date:  2016-05-18       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.